GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma

por Williams, Pete A., Braine, Catherine E., Foxworth, Nicole E., Cochran, Kelly E., John, Simon W. M.
Publicado 2017

Nicotinamide treatment robustly protects from inherited mouse glaucoma

por Williams, Pete A., Harder, Jeffrey M., Cardozo, Brynn H., Foxworth, Nicole E., John, Simon W. M.
Publicado 2018

Nicotinamide and WLD(S) Act Together to Prevent Neurodegeneration in Glaucoma

por Williams, Pete A., Harder, Jeffrey M., Foxworth, Nicole E., Cardozo, Brynn H., Cochran, Kelly E., John, Simon W. M.
Publicado 2017

Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice

por Harder, Jeffrey M., Williams, Pete A., Soto, Ileana, Foxworth, Nicole E., Fernandes, Kimberly A., Freeburg, Nelson F., Libby, Richard T., John, Simon. W. M.
Publicado 2018

Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice

por Harder, Jeffrey M., Williams, Pete A., Braine, Catherine E., Yang, Hongtian S., Thomas, Jocelyn M., Foxworth, Nicole E., John, Simon W. M., Howell, Gareth R.
Publicado 2020

Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma

por Williams, Pete A., Braine, Catherine E., Kizhatil, Krishnakumar, Foxworth, Nicole E., Tolman, Nicholas G., Harder, Jeffrey M., Scott, Rebecca A., Sousa, Gregory L., Panitch, Alyssa, Howell, Gareth R., John, Simon W. M.
Publicado 2019

Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin

por Harder, Jeffrey M., Guymer, Chelsea, Wood, John P. M., Daskalaki, Evangelia, Chidlow, Glyn, Zhang, Chi, Balasubramanian, Revathi, Cardozo, Brynn H., Foxworth, Nicole E., Deering, Kelly E., Ouellette, Tionna B., Montgomery, Christa, Wheelock, Craig E., Casson, Robert J., Williams, Pete A., John, Simon W. M.
Publicado 2020